Mechanism of inhibition of mammalian DNA topoisomerase I by heparin
- PMID: 3032152
- PMCID: PMC1147532
- DOI: 10.1042/bj2410111
Mechanism of inhibition of mammalian DNA topoisomerase I by heparin
Abstract
We have previously shown that heparin is a potent inhibitor of a mammalian DNA topoisomerase I. We have now investigated the mechanism of its inhibition. This was carried out first by scrutinizing the structural features of heparin molecules responsible for the inhibition. Commercial heparin preparation was fractionated by antithrombin III-Sepharose into non-adsorbed, low-affinity and high-affinity fractions, of which only the high-affinity fraction of heparin is known to contain a specific oligosaccharide sequence responsible for the binding to antithrombin III. These fractions all exhibited essentially similar inhibitory activities. Furthermore, when chemically sulphated to an extent comparable with or higher than heparin, otherwise inactive glycosaminoglycans such as heparan sulphate, chondroitin 4-sulphate, dermatan sulphate and neutral polysaccharides such as dextran and amylose were converted into potent inhibitors. Sulphated dermatan sulphate, one of the model compounds, was further shown to bind competitively to the same sites on the enzyme as heparin. These observations strongly suggested that topoisomerase inhibition by heparin is attributable primarily, if not entirely, to the highly sulphated polyanionic nature of the molecules. In a second series of experiments we examined whether heparin inhibits only one or both of the topoisomerase reactions, i.e. nicking and re-joining. It was demonstrated that both reactions were inhibited by heparin, but the nicking reaction was more severely affected than was the re-joining reaction.
Similar articles
-
Binding of heparin fractions and other polysulfated polysaccharides to plasma fibronectin: effects of molecular size and degree of sulfation of polysaccharides.Biochim Biophys Acta. 1985 Jul 26;841(1):30-41. Biochim Biophys Acta. 1985. PMID: 2861857
-
Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.Biochem J. 1988 Sep 1;254(2):547-51. doi: 10.1042/bj2540547. Biochem J. 1988. PMID: 2902851 Free PMC article.
-
Affinity chromatography of sulphated polysaccharides separately fractionated on antithrombin III and heparin cofactor II immobilized on concanavalin A--sepharose.J Chromatogr. 1993 Jun 2;615(2):215-23. doi: 10.1016/0378-4347(93)80335-2. J Chromatogr. 1993. PMID: 8335699
-
Mechanisms for the anticoagulant effect of heparin and related polysaccharides.Nouv Rev Fr Hematol (1978). 1988;30(3):155-60. Nouv Rev Fr Hematol (1978). 1988. PMID: 2971155 Review.
-
Pharmacokinetics of heparin and of dermatan sulfate: clinical implications.Adv Exp Med Biol. 1992;313:237-47. doi: 10.1007/978-1-4899-2444-5_24. Adv Exp Med Biol. 1992. PMID: 1332440 Review. No abstract available.
Cited by
-
Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.Proc Natl Acad Sci U S A. 1987 Aug;84(16):5565-9. doi: 10.1073/pnas.84.16.5565. Proc Natl Acad Sci U S A. 1987. PMID: 3039492 Free PMC article.
-
Topoisomerase I in multiple drug resistance.Cytotechnology. 1993;12(1-3):127-35. doi: 10.1007/BF00744661. Cytotechnology. 1993. PMID: 7764454 Review.
-
DNA topoisomerase I from Alcaligenes eutrophus H16.Arch Microbiol. 1990;153(2):134-8. doi: 10.1007/BF00247810. Arch Microbiol. 1990. PMID: 2154165
-
Heparin and liver heparan sulfate can rescue hepatoma cells from topotecan action.Biomed Res Int. 2014;2014:765794. doi: 10.1155/2014/765794. Epub 2014 Sep 7. Biomed Res Int. 2014. PMID: 25309924 Free PMC article.
-
Purification and characterization of PCR-inhibitory components in blood cells.J Clin Microbiol. 2001 Feb;39(2):485-93. doi: 10.1128/JCM.39.2.485-493.2001. J Clin Microbiol. 2001. PMID: 11158094 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials